Dow Down 0.62% Nasdaq Down 1.14%

More On GENT

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Gentium S.p.A (GENT)

-NasdaqGM
55.04 Mar 7, 4:00PM EST
Prev Close:55.04
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:78.00
Beta:1.99
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:7.26 - 59.25
Volume:0
Avg Vol (3m):199,961
Market Cap:N/A
P/E (ttm):114.43
EPS (ttm):0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GENT 0.00%N/A
BMY85.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gentium S.p.A., a biopharmaceutical company, engages in the research and development of drugs derived from DNA and DNA molecules. The company develops and manufactures defibrotide, an investigational drug based on a mixture of single-and double-st... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback